Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
356 results
  1. List of Excluded Studies - Radiation Therapy for Brain Metastases - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK571233
    ... Chen X, et al. Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with ...
  2. B-Cell Non-Hodgkin Lymphoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK592890
    ... The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma. ...
  3. Gastrointestinal Stromal Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65712
    ... in: Treatment of Resectable Primary GISTs Advanced GIST Tyrosine Kinase Inhibitors Imatinib Demetri GD, von Mehren M, Blanke CD, et al.: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. ...
  4. Hairy Cell Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65741
    ... Jones J, Andritsos L, Kreitman RJ: Efficacy and safety of the Bruton tyrosine kinase inhibitor ibrutinib in patients with hairy cell ...
  5. List of Excluded Articles - The Role of Immunotherapy in the Treatment of Asthma - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK513526
    ... Saenz MM, Villa-Arango AM, Cardona-Villa R. [Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with ...
  6. Jaundice | Icterus | MedlinePlus 
    https://medlineplus.gov/jaundice.html
    ... from MEDLINE/PubMed (National Library of Medicine) Article: Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination... Article: Risk assessment of hyperbilirubinemia ...
  7. Detailed Methods - Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: A Systematic Review ... 
    https://www.ncbi.nlm.nih.gov/books/NBK565986
    ... in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (intracellular signaling pathways: tyrosine kinase and mTOR inhibitors). Clin Microbiol Infect . 2018; ...
  8. Colon Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65858
    ... trial. Regorafenib Regorafenib is an inhibitor of multiple tyrosine kinase pathways, including VEGF. In 2012, the FDA approved regorafenib for patients who had progressed on previous therapy. Evidence (regorafenib): The safety and effectiveness of regorafenib were evaluated in a ...
  9. Rectal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65965
    ... OS. Regorafenib Regorafenib is an inhibitor of multiple tyrosine kinase ... The safety and effectiveness of regorafenib were evaluated in a ...
  10. pdf2019NewMeShHeadingsSingleColumn.pdf 
    https://www.nlm.nih.gov/.../2019NewMeShHeadingsSingleColumn.pdf
    ... associated with X-LINKED AGAMMAGLOBULINEMIA. Tree locations: Protein-Tyrosine Kinases ... Aggressive-Driving) PI: Automobile Driving (2000-2018) Tree ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last